OBJECTIVE: To assess the impact of gout on health-related quality of life (HRQoL) among patients in three large US cities. METHODS: Gout patients completed the Short Form-36 (SF-36) and a series of questions regarding their gout, comorbidities and demographics. Their physicians confirmed the gout diagnosis and evaluated the severity of patient's gout. The differences in mean norm-based SF-36 scores between the US norms and gout patients and between subgroups of gout patients were calculated. The relative weight and significance of gout-related characteristics associated with patients' HRQoL were also calculated. RESULTS: The majority of the patients were males with a mean age of 62.2 years and median disease duration of 13.8 years. Most were overweight/obese with several comorbidities. Half of the patients experienced three or more gout attacks per year with a typical gout attack involving five joints and lasting for at least 4 days. The Physical Component Summary (PCS) and Mental Component Summary (MCS) was significantly lower for gout patients (P < 0.002 and P < 0.001, respectively). Among gout patients, the mean PCS and MCS were lower for those with more frequent gout attacks and greater number of affected joints (P < 0.005 and P < 0.001, respectively). After adjusting for age, gender and comorbidities, the number of joints involved during a typical and the worst gout attack had the greatest impact on patient's PCS and MCS. CONCLUSION: Gout patients had clinically significant lower HRQoL than their age-matched US norm. Comorbidities and several additional gout-related factors significantly impacted the overall HRQoL.
OBJECTIVE: To assess the impact of gout on health-related quality of life (HRQoL) among patients in three large US cities. METHODS:Goutpatients completed the Short Form-36 (SF-36) and a series of questions regarding their gout, comorbidities and demographics. Their physicians confirmed the gout diagnosis and evaluated the severity of patient's gout. The differences in mean norm-based SF-36 scores between the US norms and goutpatients and between subgroups of goutpatients were calculated. The relative weight and significance of gout-related characteristics associated with patients' HRQoL were also calculated. RESULTS: The majority of the patients were males with a mean age of 62.2 years and median disease duration of 13.8 years. Most were overweight/obese with several comorbidities. Half of the patients experienced three or more gout attacks per year with a typical gout attack involving five joints and lasting for at least 4 days. The Physical Component Summary (PCS) and Mental Component Summary (MCS) was significantly lower for goutpatients (P < 0.002 and P < 0.001, respectively). Among goutpatients, the mean PCS and MCS were lower for those with more frequent gout attacks and greater number of affected joints (P < 0.005 and P < 0.001, respectively). After adjusting for age, gender and comorbidities, the number of joints involved during a typical and the worst gout attack had the greatest impact on patient's PCS and MCS. CONCLUSION:Goutpatients had clinically significant lower HRQoL than their age-matched US norm. Comorbidities and several additional gout-related factors significantly impacted the overall HRQoL.
Authors: Katarzyna Piotrowicz; Katia Noyes; Jeffrey M Lyness; Scott McNitt; Mark L Andrews; Andrew Dick; W Jackson Hall; Arthur J Moss; Wojciech Zareba Journal: Eur Heart J Date: 2007-02-12 Impact factor: 29.983
Authors: John D Osborne; James S Booth; Tobias O'Leary; Amy Mudano; Giovanna Rosas; Phillip J Foster; Kenneth G Saag; Maria I Danila Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Dinesh Khanna; Andrew J Sarkin; Puja P Khanna; Marian M Shieh; Arthur F Kavanaugh; Robert A Terkeltaub; Susan J Lee; Jasvinder A Singh; Jan D Hirsch Journal: Rheumatology (Oxford) Date: 2011-03-03 Impact factor: 7.580
Authors: Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar Journal: Clin Rheumatol Date: 2014-08 Impact factor: 2.980
Authors: Michael A Becker; H Ralph Schumacher; Luis R Espinoza; Alvin F Wells; Patricia MacDonald; Eric Lloyd; Christopher Lademacher Journal: Arthritis Res Ther Date: 2010-04-06 Impact factor: 5.156